Healthcare technology

Biomedical/pharma, Healthcare technology, Immunology, Oncology, Personal/public health

Buses full of innovators, lab doors wide open and conversations to spark collaboration—that was the vibe for BioWin on Tour on 24 September 2025, co-organized with AWEX. It was a whirlwind visit, with fifty international delegates from nine countries visiting two of Wallonia’s flagship science hubs—LégiaPark and BioPark Charleroi—discovering the region’s twin strengths of ATMPs and nuclear medicine.
Biovia is Europe’s first industry-led One Health innovation cluster—uniting medical biotech, medtech, digital health, agtech and industrial biotech to advance human and planetary health. Katrien Lorré explains how this unified approach benefits companies by unlocking opportunities and fostering a better environment for health innovation.
ATMPs (advanced therapy medicinal products) are expected to reach a global value of 80 billion euro in 2032. While it can be tempting to try to go it alone, the fastest and most intelligent way to advance is by advancing together. The event, Advanced Therapies in Belgium, presents such an occasion, offering a space for innovative ideas and featuring speakers from the forefront of the Belgian and international ATMP innovation.
In a hospital, numerous single-use masks, gloves, syringes, and more are thrown away every day to safeguard patients. However, this linear supply chain leaves a large footprint and can have negative effects on our environment and public health. It seems that the road to achieving sustainable healthcare is not straightforward, but circular.
Luxembourg may be one of the smallest nations in the world, at just over 2,500 square kilometers and around 670,000 inhabitants, but it packs a punch in the global life sciences ecosystem. With world-class research institutes, startup accelerators, and the country’s growing digital prowess, Luxembourg is attracting global talent and putting digital healthtech solutions front and center. So, how did the Grand Duchy establish and grow its thriving research and startup landscape, and what is the vision for the future?
An estimated 50 million people in Europe regularly go for a run, including almost 20% of the Belgian population. While most might not be running marathons at an Olympic pace, the chance of getting injured can feel inevitable to any runner. This fear is justified, as around half of all runners experience at least one injury annually. But what’s driving this unsettling statistic, and how can runners potentially reduce the likelihood of a dreaded injury spell?
For scientists or budding entrepreneurs with the next big idea in sports tech, the road from conceptualization to product can seem perilous, with many pitfalls along the way. To stand a chance at getting your research out of the lab and into the hands of athletes, it’s essential to start off on the right foot. Read on to see how the collaboration of scientists and sports tech development experts is helping this unique ecosystem in Belgium to flourish.
Ultrasound is a powerful technology that helps healthcare professionals take the first images of your child in utero and allows us to look at soft tissue, such as muscles, tendons, and most internal organs. But ultrasound largely requires patients to be static, meaning crucial information is missed about how muscles or organs behave when they’re most strained during exercise. Now, novel advances and innovative designs from the Netherlands and beyond are bringing ultrasound devices into the wearable medtech era, with exciting possibilities to monitor muscles and organs in motion. These technologies are pushing boundaries in both the medical and sports worlds while helping to diagnose patients, to help athletes train, or to shorten their road to recovery.
Training session after training session, top athletes must push themselves to the limits to test their bodies. Although pain is a clear emergency signal, athletes in pain may push themselves even further. This makes them vulnerable to injuries and severe pain conditions including acute and chronic lower back pain. Although there are several treatment options to alleviate the symptoms, the treatment of acute and chronic pain is not straightforward. A multidisciplinary approach is required, and more treatment options are needed that focus on treating the underlying cause.
While a vast majority of women experience vaginal yeast infections, research has fallen short in providing an effective treatment approach. However, hope has emerged recently with the development of new model systems that allow exploration of the complex vaginal environment. Organ-on-chip models enable researchers to examine the interactions between human cells and microbes in a more accurate manner, offering the potential for the development of new therapies.
Innovative Smart Contact Lens Developer Awarded €2.5M in Funding for Groundbreaking Ocular Health Technology
In December 2023, Azalea Vision announced the first test of their smart contact lens on a real person. This demonstration showcased the first functional prototype of their smart lens, known as the ALMA lens, which was developed by the company to address ocular disorders characterized by the inability to effectively filter light.
In a significant milestone, Azalea Vision, pioneering start-up on a mission to revolutionize the treatment of ocular disorders, announces the successful demonstration of ALMA Lens, the first functional prototype of the Azalea smart contact lens’ platform.
Even though endometriosis impacts millions of women globally, the condition remains poorly understood and researched, leading to delayed diagnosis and lack of effective treatment. Encouragingly, there are promising recent developments in the field coming from Belgium. Professor Hugo Vankelecom’s research group at KU Leuven uses advanced cellular models, known as organoids, to delve into the disease and expedite the drug discovery process. The Danish BioInnovation Institute now offers the team an incubation program to pave the way towards industrial success.
The AIPLANT project aims to reduce complications from dental implant surgery using AI-based preoperative planning. The project is a collaboration between the Centre for Dentomaxillofacial Imaging at UZ Leuven, AI startup Relu, and Xentro Dental.